(Q52252206)

28 April 2018

title

A mathematical model of breast and ovarian cancer treated with paclitaxel. (English)

1 reference

28 April 2018

1 reference

1 reference

Panetta JC

1

1 reference

28 April 2018

publication date

1 December 1997

1 reference

28 April 2018

number of pages

25

1 reference

based on heuristic

inferred from page(s)

published in

Mathematical Biosciences

1 reference

28 April 2018

volume

146

1 reference

28 April 2018

issue

2

1 reference

28 April 2018

page(s)

89-113

1 reference

28 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

cites work

Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Canadian-European Taxol Cooperative Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Therapeutic response to taxol of six human tumors xenografted into nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Cell proliferation kinetics of normal and tumour tissue in vitro: quiescent reproductive cells and the cycling reproductive fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

Stability analysis of normal and neoplastic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

A mathematical model of the development of drug resistance to cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

The problem of the quiescent cancer cell.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-5564%2897%2900077-1

10.1016/S0025-5564(97)00077-1

7 January 2021

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018